- 28 November, 2024
Arena Pharmaceuticals up 90% after acquisition announcement
Pfizer Inc (NYSE: PFE) executed a definitive agreement with Arena Pharmaceuticals (Nasdaq: ARNA), under which Pfizer Inc will acquire Arena Pharmaceutical for a total equity value of around
Harley-Davidson shares are up 20% on Monday: explore why
Shares of Harley-Davidson Inc (NYSE: HOG) were up nearly 20% this morning after the American motorcycle manufacturer said its EV unit is set to go
Dow Jones, the S&P 500, and Nasdaq price forecast after last week rally
The Dow Jones, the S&P 500, and the Nasdaq advanced on a weekly basis following optimism that the Omicron variant of coronavirus may have smaller
Should I invest in Garmin shares ahead of the ex-dividend date?
Garmin Ltd. (NYSE: GRMN) shares have weakened from $178.8 to $132.23 since August 31, 2021, and the current price stands at $136.11. Demand for active
Is the Meta Platforms stock correction over?
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
Should I buy AT&T shares in December 2021?
AT&T Inc. (NYSE: T) shares have weakened more than 7% since the beginning of December and continue to trade near their lowest point since the
Pro on Beyond Meat: ‘fundamentals and technicals suggest there’s more downside’
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
Should I buy Tyson Foods shares after the company’s management set aggressive targets?
Tyson Foods, Inc. (NYSE: TSN) shares are advancing after the company’s management set aggressive targets at an investor event this week. Tyson set aggressive targets
Moderna drops 25% as its MRNA flu vaccine’s phase 1 data
Moderna Inc. (NASDAQ: MRNA) is a biotech firm that focuses on mRNA vaccines and therapeutics. The company announced the results of the mRNA-1010 flu vaccine candidate.
Mr Wonderful just bought more of this underperforming stock
Shares of Coinbase Global Inc (NASDAQ: COIN) have tanked nearly 30% since November 9th, but the underperformance was not sufficient to make Kevin O’Leary change